cadenas

Innovative Therapies for Children with Cancer in Europe

  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC / ANZCHOG Partnership

ITCC / ANZCHOG Partnership

ITCC and ANZCHOG signed during the ITCC Annual Meeting a MoU to facilitate cooperation

Welcome to the 2017 Annual Meeting

Welcome to the 2017 Annual Meeting

ITCC held its Annual Meeting in Paris on November 9-10, 2017

Learn More

Find a clinical trial

Innovative Therapies for Children with Cancer

The Innovative Therapies for Children with Cancer (ITCC) Consortium was created in 2003. It is a non profit organisation under the French Law.

ITCC gathers 54 European Paediatric Oncology Departments with expertise in conducting early phase trials in children and adolescents, and 22 European research laboratories.

The aim of this organisation is to develop novel therapies for the treatment of paediatric and adolescent cancers in cooperation with regulatory bodies, pharmaceutical enterprises, parents and patients.

 

In January 2011 ITCC was established as a European Category 1 Network for Paediatric Research at the European Medicines Agency (EnprEMA).

 

Its structure comprises several Committees which take care and contribute to a particular issue in the development of novel therapeutic strategies in paediatric oncology.

Find a center

Take a look at the ITCC map and discover our 54 centres
Carte des centres
Special partners